Skip to main content

Advertisement

Log in

Recurrent Varicella following Steroids and Fingolimod in a Multiple Sclerosis Patient

  • LETTER TO THE EDITOR
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1

References

  • Aandahl EM, Michaëlsson J, Moretto WJ et al (2004) Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 78:2454–2459

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Cohen JA, Barkhof F, Comi G et al (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362:402–415

    Article  PubMed  CAS  Google Scholar 

  • Hill G, Chauvenet AR, Lovato J et al (2013) Recent steroid therapy increases severity of varicella in children with acute lymphoblastic leukemia. Pediatrics 116:e525–e529

    Article  Google Scholar 

  • Li S, Gowans EJ, Chougnet C et al (2008) Natural regulatory T cells and persistent viral infection. J Virol 82:21–30

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Ratchford JN, Costello K, Reich S et al (2012) Varicella Zoster virus encephalitis and vasculopathy in a patient treated with fingolimod. Neurology 79:2002–2004

    Article  PubMed  PubMed Central  Google Scholar 

  • Ricklin ME, Lorscheider J, Waschbisch A et al (2013) T-cell response against varicella-zoster virus in fingolimod-treated MS patients. Neurology 81:1–8

    Article  Google Scholar 

  • Seissler N, Schmitt E, Hug F et al (2012) Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR + −Treg-cells in transplanted patients. Transpl Immunol 27:157–161

    Article  PubMed  CAS  Google Scholar 

  • Serpero LD, Filaci G, Parodi A, et al (2013) Fingolimod modulates peripheral effector and regulatory T cells in MS patients. J Neuroimmune Pharm (Epub 2013 May 7). doi:10.1007/s11481-013-9465-5

  • Suvas S, Kumaraguru U, Pack CD et al (2003) CD4+ CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 198:889–901

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Verstraeten T, Jumaan AO, Mullooly JP et al (2003) A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination. Pediatrics 112:e98–e103

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Partially supported by FISM – Fondazione Italiana Sclerosi Multipla – cod. 2012/R/4.

Ethics Committee

Patient cytofluorimetric data derives from a study exploring the effects on fingolimod on a number of cells, including Treg, for which Ethics Committee approval was obtained.

Consent

All authors consent to manuscript submission.

Conflict of Interest Statement

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Ferraro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferraro, D., De Biasi, S., Vitetta, F. et al. Recurrent Varicella following Steroids and Fingolimod in a Multiple Sclerosis Patient. J Neuroimmune Pharmacol 8, 1059–1061 (2013). https://doi.org/10.1007/s11481-013-9510-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-013-9510-4

Keywords

Navigation